BMO Capital maintained an Outperform rating on ZS Pharma (NASDAQ: ZSPH) and raised its price target to $83.00 (from $70.00).

For an analyst ratings summary and ratings history on ZS Pharma click here. For more ratings news on ZS Pharma click here.

Shares of ZS Pharma closed at $74.73 yesterday.

Analyst PT Change

ZS Pharma's (ZSPH) Price Target Raised to $110 at William Blair September 11, 2015 8:21 AM ZS Pharma (ZSPH) to Resume Trading at 5:50 PMSeptember 10, 2015 5:36 PM ZS Pharma (ZSPH) Participated in Preliminary Discussions with ActelionSeptember 10, 2015 5:32 PM ZS Pharma Corporate StatementSeptember 10, 2015 5:31 PM Form 8-K ZS Pharma, Inc. For: Sep 10September 10, 2015 5:30 PM Market Wrap: Markets Gain as Volatility Subsides; GE Moves to Sell More Assets; Initial Claims Flat W/WSeptember 10, 2015 5:24 PM Actelion Confirms Discussions with ZS Pharma (ZSPH)September 10, 2015 5:17 PM ZS Pharma (ZSPH) halted with news pendingSeptember 10, 2015 4:32 PM Relypsa (RLYP) Gains in Sympathy with ZS Pharma (ZSPH)September 10, 2015 2:39 PM ZS Pharma (ZSPH) Halted on LUDPSeptember 10, 2015 2:25 PM Actelion Said to Make Approach for ZS Pharma (ZSPH)September 10, 2015 2:24 PM UPDATE: ZS Pharma (ZSPH) Shares Surge; Conference Cancellation ConfirmedSeptember 10, 2015 10:14 AM